1-45693309-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000372025.5(TMEM69):c.148C>T(p.Leu50Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,614,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000372025.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM69 | NM_016486.4 | c.148C>T | p.Leu50Phe | missense_variant | 3/3 | ENST00000372025.5 | NP_057570.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM69 | ENST00000372025.5 | c.148C>T | p.Leu50Phe | missense_variant | 3/3 | 1 | NM_016486.4 | ENSP00000361095 | P1 | |
TMEM69 | ENST00000496366.1 | n.186C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000144 AC: 36AN: 249562Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135396
GnomAD4 exome AF: 0.000245 AC: 358AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.000238 AC XY: 173AN XY: 727248
GnomAD4 genome AF: 0.000145 AC: 22AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.148C>T (p.L50F) alteration is located in exon 3 (coding exon 2) of the TMEM69 gene. This alteration results from a C to T substitution at nucleotide position 148, causing the leucine (L) at amino acid position 50 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at